Supply chain guidance in the works
This article was originally published in The Gold Sheet
Executive Summary
FDA plans to issue several supply-chain-related guidance documents in the coming year, the agency said in its annual guidance agenda, published Aug. 7 in the Federal Register. The commissioner's office is working on guidance for good importer practices. The Center for Drug Evaluation and Research has guidance in the works on active pharmaceutical ingredients, as well as on adding physical-chemical identifiers to solid oral dosage forms for anti-counterfeiting. The notice indicates other drug quality related guidance documents in preparation, including ones on annually reportable post-approval changes and parametric release (see story p. 1) as well as immunogenicity assessment; immunogenicity related assay development; standards recognition; penicillin definition, nonpenicillin beta-lactam contamination; process validation; genotoxic and carcinogenic impurities; and private labs
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.